Nuvya
Loading...Nuvya Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is currently no usage information available for this product. We apologize for any inconvenience.
History
There is currently no drug history available for this drug.
Other Information
NUVYA® is comprised of 100 mg of Tamoxifen Citrate USP, 150 mg of Adapalene USP, and 1 g of Diclofenac Sodium USP for dermatological use.1 NUVYA® also contains a Cream Base containing purified water, white petrolatum, sorbitol solution, cetearyl alcohol, propylene glycol, ceteareth-20, simethicone, glyceryl monostearate, polyethylene glycol monostearate, sorbic acid and BHT. When mixed as instructed, the final product provides a homogeneous cream mixture containing Tamoxifen Citrate, Adapalene and Diclofenac Sodium as contained in NUVYA®.
- 1
- Certificate of analysis on file
Sources
Nuvya Manufacturers
-
Accumix Pharmaceuticals
![Nuvya (Tamoxifen Citrate, Adapalene And Diclofenac Sodium) Kit [Accumix Pharmaceuticals]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Nuvya | Accumix Pharmaceuticals
The pharmacist must mix contents of each container with appropriate amount of Cream Base yielding a final volume of 50 grams at the time of dispensing. Pharmacist may utilize appropriate diluents if needed from the respective active component Material Safety Data Sheet only. For dermatological use only. This product should not be administered orally.
Login To Your Free Account